课题基金 / 基金详情

reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)

reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
用于治疗 HIV 诊所兴奋剂使用的 reSET:护理优化支持治疗依从性 (COSTA)
批准号:
10553554
负责人:
Adam Wayne Carrico
金额:
$93.23万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-07-31
关键词:
AIDS/HIV problemAbstinenceAcquired Immunodeficiency SyndromeAdoptionAdultAfrican AmericanAfrican American populationAgeAreaBlack PopulationsBlack raceBloodCaringClinicCognitive TherapyCommunitiesComputer softwareConsentContinuity of Patient CareDiagnosisDiseaseDrug Use DisorderDrug usageEffectivenessEnvironmentEpidemicEthnic OriginEthnic groupFDA approvedFaceFoundationsHIVHIV InfectionsHIV diagnosisHealthHealth InsuranceHealthcareHealthcare SystemsHepatitisImprisonmentInterventionLaboratoriesLatinxLettersLos AngelesMaintenanceMediator of activation proteinMedicalMinority MenModelingNot Hispanic or LatinoOutcomeOutpatientsPain ClinicsParticipantPatientsPersonsPharmaceutical PreparationsPharmacotherapyPopulationPsychological reinforcementPsychosocial Assessment and CarePublic HealthRaceRandomizedReach Effectiveness Adoption Implementation and MaintenanceReportingRiskSexually Transmitted DiseasesSiteSocial supportSoftware DesignSpine painStimulantSubstance Use DisorderTestingTherapeuticUnited StatesUnited States National Institutes of HealthUrineViralViral Load resultVisitantiretroviral therapyarmbasecontingency managementcost effectivenessdesigneconomic impacteffectiveness testingethnic diversityethnic minorityexperiencefollow-uphandheld mobile devicehealth care settingshigh risk sexual behaviorimprovedmedication compliancemen who have sex with menoff-label usepreventprimary outcomepsychosocialracial and ethnicrecruitsecondary outcomesexual minorityskillsstimulant usestimulant use disordersubstance use treatmenttherapy adherencetooltransmission processtreatment adherencetreatment as preventiontreatment as usualtreatment centertreatment optimizationtreatment programtreatment servicesvirtual

项目摘要

项目成果

Adam Wayne Carrico的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
Abstract In 2019 men who have sex with men (MSM) accounted for 70% of the 34,800 new HIV diagnoses and 66% of the 1.2 million total HIV infections in the United States. Among this high priority population, MSM living with HIV, stimulant use is a major barrier to achieving viral load control, necessary for reducing HIV transmission and improving long term health outcomes. Additionally, having HIV and substance use disorder diagnoses, as well as being racial/ethnic minority MSM, exacerbate the barriers to accessing and completing in-person drug treatment services. reSET is the first FDA approved prescription mobile therapeutic software designed to treat substance use disorders in adults. In patients with a primary diagnosis of stimulant use disorder, reSET has been found efficacious in reducing stimulant use, both for patients who are already in drug treatment and as a standalone substance use treatment for incarcerated persons. However, reSET has not been tested in any medical settings, including HIV care settings, as an all-virtual SUD treatment for patients living with HIV. To effectively mitigate the HIV epidemic among ethnically diverse MSM living with HIV, we propose a two-arm RCT of an all-virtual 12-week stimulant disorder treatment for MSM living with HIV who are on antiretroviral therapy (ART). The study will include 426 racial/ethnically diverse MSM (~50% African American and ~23% Latinx). Participants will be patients of the AIDS Healthcare Foundation (AHF) HIV treatment centers (10 participating clinics) located in four US metro areas with AHF’s highest numbers of HIV cases with stimulant use (Atlanta, Dallas/Fort Worth, Fort Lauderdale and Los Angeles). Participants with moderate to severe stimulant use disorder will be randomized to two conditions: (1) referral to outpatient substance use disorder treatment (treatment as usual/ control condition) or (2) reSET (experimental condition) to: (Aim 1a) test the effectiveness of standalone all-virtual reSET in achieving lower stimulant use across 3-, 9- and 15-months compared to TAU; (Aim 1b) test the effectiveness of standalone all-virtual reSET in increasing the likelihood of viral suppression across the 3-, 9- and 15-months follow-up periods compared to TAU; (Aim 2) examine the moderating effect of race/ethnicity (Blacks/African Americans, Latinx, and Whites) on the relationship between condition and stimulant use (primary outcome) and VL suppression (secondary outcome); and (Aim 3) to evaluate in the context of the RE-AIM framework, the reach, effectiveness, adoption, implementation, economic impact, and implementation maintenance of the experimental treatment within AHF. If found effective, reSET implemented in conjunction ART could, present a major scalable advancement in optimizing ‘treatment as prevention’ among sexual minorities living with HIV and stimulant use disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men
  • 批准号:
    10895784
  • 项目类别:
  • 资助金额:
    $65.32万
  • 财政年份:
    2023
  • 负责人:
    Adam Wayne Carrico
  • 依托单位:
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men
  • 批准号:
    10898254
  • 项目类别:
  • 资助金额:
    $10.95万
  • 财政年份:
    2023
  • 负责人:
    Adam Wayne Carrico
  • 依托单位:
海外基金